Skip to main content

Table 1 Patients switched to ETV with an undetectable viral load

From: Etravirine use in clinical practice: 48-week data from a single centre cohort

VL< 50 copies/ml

12 weeks (n = 36)

24 weeks (n = 24)

36 weeks (n = 17)

48 weeks (n = 8)

Intention to treat

100%

88%

94%

88%

On treatment

100%

91%

100%

100%